Top Companies in the Structural Biology and Molecular Modeling Market Is Essential For Your Success. Read This to Find Out Why
Structural Biology and Molecular Modeling Projected Market 2028: USD 18.1 Billion
Market Overview:
According to Vantage market research, the Global Structural Biology and Molecular Modeling market is valued at USD 6.1 Billion in 2021 and is projected to attain a value of USD 18.1 Billion by 2028 at a CAGR of 17.1% during the forecast period, 2022–2028. Structural biology and molecular modeling is a technique that is used in the healthcare industry to get remedies for a number of diseases. Thus, it increases the demand for structural biology and molecular modeling market in the coming years. In addition, the increasing frequent occurrence of chronic diseases is augmenting the growth of the structural biology and molecular modeling market in upcoming years. Furthermore, the various governments are taking an interest in providing good quality medicine. This is also a key parameter for influencing the growth of market during the projected time period.
Government across the world is considered as a key parameter in the development of the healthcare sector and giving quality of medicine. In addition, the increasing geriatric population and increasing volume of patient demographics are concentrating government focus on the development of Healthcare infrastructure. Furthermore, huge investment in medical research activity increases the demand for structural biology & molecular modeling techniques for new drug discovery, which, in turn, drives the market growth in recent years.
Following are the top leading companies in the Structural Biology and Molecular Modeling Market:
Company Name |
Revenue in USD |
|
<$5 Million |
|
$6 Billion |
|
$19 Million |
|
$2 Billion |
|
$5 Million |
|
$4 Billion |
|
$3 Billion |
|
$39 Billion |
Acellera is devoted to bringing state-of-the-art technologies to drug discovery. Founded in 2006, the company leverages the use of novel accelerator processor technology (GPU) applied to molecular dynamics. The company developed the first online platform for drug design based on deep learning and is now leading the introduction of machine learning techniques into the drug discovery pipeline. The company accelerates the transition to rational, computerized drug discovery via simulations and machine learning.
Agilent is a leader in life sciences, diagnostics, and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications, and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give the highest confidence to their customers. Agilent focuses its expertise on six key markets Food, Environmental & Forensics, Pharmaceutical, Diagnostics, Chemical & Energy, and Research.
Biomax Informatics provides services and software solutions for efficient decision-making and knowledge management at the intersection of life sciences, healthcare, and information technologies. The company facilitates digital transformation within biotech, pharma, agriculture, food, and chemical industries as well as research institutes. The company offers a range of standard products addressing digitalization needs, like semantic search, brain imaging, or clinical integration. These products are based on the BioXM™ technology platform of Biomax – the fully configurable and customizable Knowledge Management Environment.
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. The company's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with their customers, the company is enabling innovation, improved productivity, and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics, and proteomics research and clinical microbiology.
Chemical Computing Group was founded in 1994, the company is a software company specializing in research software for computational chemistry, bioinformatics, cheminformatics, docking, pharmacophore searching, and molecular simulation. The company's main customer base consists of pharmaceutical and biotechnology companies, as well as academic research groups. Its main product, Molecular Operating Environment (MOE), is written in a self-contained programming system, the Scientific Vector Language (SVL). The company is a developer and provider of Molecular Modeling, Simulations, and Machine Learning software to Pharmaceutical and Biotechnology companies as well as Academic institutions throughout the world.
Dassault Systemes is a 3Dexperience company, that provides businesses and people with virtual universes to imagine sustainable innovations. The company provides virtual worlds that allow its clients to create innovative experiences for their own customers. The company's aim is to achieve a new development model to address the major challenges facing the world today. The company works on various branches of science mathematics, biology, chemistry, physics, and geology to break down silos of knowledge and find the most innovative, sustainable solutions for the future.
Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. These systems are enabling studies that were not even imaginable just a few years ago, and moving the company closer to the realization of personalized medicine. With rapid advances in technology taking place, the company offers solutions that are not only innovative, but flexible, and scalable, with industry-leading support and service. The company strives to meet the challenge by placing a high value on collaborative interactions, rapid delivery of solutions, and meeting the needs of their customers.
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. The company's mission is to enable its customers to make the world healthier, cleaner, and safer. The company supports its customers to accelerate life sciences research, solve complex analytical challenges, increase productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies. The company's global team delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.
Get Free Sample Here @ https://www.vantagemarketresearch.com/structural-biology-and-molecular-modeling-market-1333/request-sample
For More Information about each of these companies.
Vantage Market Research Report comes up with a detailed analysis of each major player in the industry. The Study provides Global market size & share, Emerging trends, In-depth analysis of key players, Development opportunities, Sales, Revenue Forecast
Read Our latest blog: https://v-mr.biz/scrubber-system-market